Fortrea Holdings Inc. (FTRE)

In April 2026, Fortrea unveiled "Fortrea Intelligent Technology™," leading to a stock increase. In March 2026, the company announced inducement awards and TD Cowen upgraded Fortrea's rating. In February 2026, Fortrea reported its Fourth Quarter and Full-Year 2025 results and issued Full-Year 2026 guidance, which saw the stock increase, but missed Q4 earnings and revenue estimates and expanded its executive team. In January 2026, an investigation was initiated by Kahn Swick & Foti, LLC. Over the past 12 months, the stock has gained 76.2%.

While detailed breakdowns are limited, Fortrea's Q4 2025 earnings call mentions seasonality and lumpiness in pass-through revenue in the context of Q1. This suggests seasonal fluctuations in demand or revenue recognition, influenced by clinical trial cycles and associated costs.

Fortrea Holdings, Inc. is a global contract research organization providing clinical development solutions to the life sciences industry. Spun off from Labcorp in July 2023 and headquartered in Durham, North Carolina, Fortrea manages clinical trials from Phase I through Phase IV and offers post-approval services, focusing on areas like oncology and rare diseases. The company also provides technology solutions to streamline randomization, optimize trial drug supply, and minimize operational costs.

Fortrea Holdings, Inc. has a global presence, operating in over 90 countries. The company maintains primary office locations in the United States, the United Kingdom, China, India, and Singapore, supported by field operations in numerous other jurisdictions worldwide.

Fortrea's brand reputation has faced scrutiny, highlighted by an investigation initiated by Kahn Swick & Foti, LLC. Analyst ratings show a consensus "Hold," with mixed recommendations. Bull arguments emphasize potential benefits from outsourced clinical trials and AI investments, while bear arguments point to operational risks and weak financial performance, including missed Q4 2025 earnings and revenue estimates.

Fortrea Holdings Inc. has a diverse ownership structure, with institutional investors holding a significant portion of the company's stock. As of April 9, 2026, 359 institutional owners and shareholders held a total of 95,493,598 shares. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and Goldman Sachs Group Inc.